Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brandt

Showing results (541-550 of 549) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 549 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 6, 2024
An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registryFelice N van Erning, Teun B M van den Heuvel, Femke P C Sijtsma, et al.
Frontiers in Psychiatry|January 12, 2019
The Danish High Risk and Resilience Study-VIA 11: Study Protocol for the First Follow-Up of the VIA 7 Cohort -522 Children Born to Parents With Schizophrenia Spectrum Disorders or Bipolar Disorder and Controls Being Re-examined for the First Time at Age 11Anne A E Thorup, Nicoline Hemager, Anne Søndergaard, et al.
Cell Reports|January 5, 2022
CXCL4 drives fibrosis by promoting several key cellular and molecular processesAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2023
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter TrialEmma Sophia Zwanenburg, Charlotte El Klaver, Daniel D Wisselink, et al.
The Lancet. Oncology|June 29, 2026
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trialKoen P Rovers, Checca Bakkers, Teun B M van den Heuvel, et al.
JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
Plos One|November 23, 2022
Variation in carbon and nitrogen concentrations among peatland categories at the global scaleShaun Watmough, Spencer Gilbert-Parkes, Nathan Basiliko, et al.
BMC Cancer|April 27, 2019
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P Rovers, Checca Bakkers, Geert A A M Simkens, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 55

Showing results (541-550 of 549) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 6, 2024
An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registryFelice N van Erning, Teun B M van den Heuvel, Femke P C Sijtsma, et al.
Frontiers in Psychiatry|January 12, 2019
The Danish High Risk and Resilience Study-VIA 11: Study Protocol for the First Follow-Up of the VIA 7 Cohort -522 Children Born to Parents With Schizophrenia Spectrum Disorders or Bipolar Disorder and Controls Being Re-examined for the First Time at Age 11Anne A E Thorup, Nicoline Hemager, Anne Søndergaard, et al.
Cell Reports|January 5, 2022
CXCL4 drives fibrosis by promoting several key cellular and molecular processesAlsya J Affandi, Tiago Carvalheiro, Andrea Ottria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2023
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter TrialEmma Sophia Zwanenburg, Charlotte El Klaver, Daniel D Wisselink, et al.
The Lancet. Oncology|June 29, 2026
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trialKoen P Rovers, Checca Bakkers, Teun B M van den Heuvel, et al.
JAMA Surgery|May 19, 2021
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical TrialKoen P Rovers, Checca Bakkers, Simon W Nienhuijs, et al.
Plos One|November 23, 2022
Variation in carbon and nitrogen concentrations among peatland categories at the global scaleShaun Watmough, Spencer Gilbert-Parkes, Nathan Basiliko, et al.
BMC Cancer|April 27, 2019
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P Rovers, Checca Bakkers, Geert A A M Simkens, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 55